ABSTRACT
The patient was a 65-year-old man with marked ST-elevation myocardial infarction.
Cardiac catheterization revealed an occluded middle portion of the left anterior descending
artery and no collateral circulation. Percutaneous coronary intervention (PCI) was
performed, and ST elevation improved 5 days after PCI. Almost all electrocardiogram
(ECG) findings were normal 6 months later. Echocardiographic findings were also normal.
This case was very successful and unusual in that no ventricular aneurysm formed despite
ST elevation continuing for a few days and that ECG and left ventricular function
were nearly normal after PCI performed days after the onset in a case without collateral
circulation.
KEYWORDS
ST segment elevation myocardial infarction - percutaneous coronary intervention -
infarct size
REFERENCES
1
Murry C E, Jennings R B, Reimer K A.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation.
1986;
74
1124-1136
2
Ishihara M, Sato H, Tateishi H et al..
Implications of prodromal angina pectoris in anterior wall acute myocardial infarction:
acute angiographic findings and long-term prognosis.
J Am Coll Cardiol.
1997;
30
970-975
3
Ishihara M, Inoue I, Kawagoe T et al..
Effect of prodromal angina pectoris on altering the relation between time to reperfusion
and outcomes after a first anterior wall acute myocardial infarction.
Am J Cardiol.
2003;
91
128-132
4
Yellon D M, Hausenloy D J.
Myocardial reperfusion injury.
N Engl J Med.
2007;
357
1121-1135
5
Hausenloy D J, Yellon D M.
Time to take myocardial reperfusion injury seriously.
N Engl J Med.
2008;
359
518-520
6
van 't Hof A W, Liem A, Suryapranata H, Hoorntje J C, de Boer M J, Zijlstra F. Zwolle
Myocardial Infarction Study Group .
Angiographic assessment of myocardial reperfusion in patients treated with primary
angioplasty for acute myocardial infarction: myocardial blush grade.
Circulation.
1998;
97
2302-2306
7
Takano M, Mizuno K, Yokoyama S et al..
Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin:
serial evaluation by coronary angioscopy.
J Am Coll Cardiol.
2003;
42
680-686
8
Nissen S E, Tuzcu E M, Schoenhagen P REVERSAL Investigators et al.
Effect of intensive compared with moderate lipid-lowering therapy on progression of
coronary atherosclerosis: a randomized controlled trial.
JAMA.
2004;
291
1071-1080
9
Schartl M, Bocksch W, Koschyk D H et al..
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering
therapy on plaque volume and composition in patients with coronary artery disease.
Circulation.
2001;
104
387-392
10
Uehara M, Funabashi N, Mikami Y, Shiina Y, Nakamura K, Komuro I.
Quantitative effect of atorvastatin on size and content of non-calcified plaques of
coronary arteries 1 year after atorvastatin treatment by multislice computed tomography.
Int J Cardiol.
2008;
130
269-275
11
First International Study of Infarct Survival Collaborative Group .
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial
infarction: ISIS-1.
Lancet.
1986;
2
57-66
12
Cannon C P, Braunwald E, McCabe C H Pravastatin or Atorvastatin Evaluation and Infection
Therapy-Thrombolysis in Myocardial Infarction 22 Investigators et al.
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
N Engl J Med.
2004;
350
1495-1504
13
Schwartz G G, Olsson A G, Ezekowitz M D Myocardial Ischemia Reduction with Aggressive
Cholesterol Lowering (MIRACL) Study Investigators et al.
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:
the MIRACL study: a randomized controlled trial.
JAMA.
2001;
285
1711-1718
14
Okazaki S, Yokoyama T, Miyauchi K et al..
Early statin treatment in patients with acute coronary syndrome: demonstration of
the beneficial effect on atherosclerotic lesions by serial volumetric intravascular
ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Circulation.
2004;
110
1061-1068
15
Patti G, Pasceri V, Colonna G et al..
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes
undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized
trial.
J Am Coll Cardiol.
2007;
49
1272-1278
16
Birnbaum Y, Ashitkov T, Uretsky B F, Ballinger S, Motamedi M.
Reduction of infarct size by short-term pretreatment with atorvastatin.
Cardiovasc Drugs Ther.
2003;
17
25-30
Michiyoshi SoneM.D.
Department of Cardiology, Koto Hospital
6-8-5 Ojima Koto-ku, Tokyo 136-0072, Japan
Email: kmws862170@yahoo.co.jp